- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.12. | 1CM Inc.: SNDL & 1CM Provide Update Regarding Arrangement | 427 | Newsfile | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - December 15, 2025) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announce... ► Artikel lesen | |
| 1CM Aktie jetzt für 0€ handeln | |||||
| 15.12. | SNDL Inc.: SNDL & 1CM Provide Update Regarding Arrangement | 140 | GlobeNewswire (Europe) | EDMONTON, Alberta and TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- SNDL Inc. (Nasdaq: SNDL, CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announce that they have entered... ► Artikel lesen | |
| 07.08. | Leviathan Natural Gas Field Signs $35b Supply Deal With Egypt | 4 | Offshore Engineer | ||
| 12.07. | Kuhn stellt mit dem Profile 1.CM einen neuen kompakten Futtermischwagen vor | 1 | top agrar | ||
| 18.06. | 1CM Inc.: 1CM Receives Court Approval for Arrangement with SNDL Inc | 792 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that the Ontario Superior Court of Justice (Commercial... ► Artikel lesen | |
| 16.06. | 1CM Inc.: 1CM Announces Results of Shareholder Meeting | 504 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce the results of its annual and special meeting (the... ► Artikel lesen | |
| 20.05. | 1CM Inc.: 1CM Mails Circular for Annual and Special Meeting of Shareholders and Announces Receipt of Interim Court Order | 523 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") announces today the mailing of its management information circular for the... ► Artikel lesen | |
| 09.04. | 1CM Inc.: SNDL Enters into Agreement to Acquire Cost Cannabis and T Cannabis Locations from 1CM | 424 | Newsfile | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - April 9, 2025) - SNDL Inc. (Nasdaq: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased to announce that... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ABBVIE | 192,60 | -1,13 % | Is AbbVie a Buy, Sell, or Hold in 2026? | ||
| BRISTOL-MYERS SQUIBB | 46,620 | +0,32 % | Will the Recent Pricing Deal With the Government Impact BMY's Sales? | ||
| BIONANO GENOMICS | 1,520 | 0,00 % | Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,012 | -20,00 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Announces Debenture Extension | VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces... ► Artikel lesen | |
| PSYCHED WELLNESS | 0,008 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm | Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 82,12 | -3,00 % | Cantor Fitzgerald bestätigt "Overweight" für Bright Minds Biosciences und sieht Potenzial in Hauptwirkstoff BMB-101 | ||
| BIOHAVEN | 11,145 | +3,96 % | Biohaven Ltd.: Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder | NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization... ► Artikel lesen | |
| HARROW | 50,09 | -0,14 % | Harrow, Inc.: Harrow Health, Inc. Announces Closing of Acquisition of Melt Pharmaceuticals | NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 5,990 | +0,34 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Broadens Patent Estate for Anaphylm | New patents extend protection for Anaphylm into 2037Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and only oral medication for the rescue treatment of severe... ► Artikel lesen | |
| UNIVERSE PHARMACEUTICALS | 5,620 | +31,00 % | Universe Pharmaceuticals INC - 6-K, Report of foreign issuer | ||
| ETON PHARMACEUTICALS | 16,830 | -0,94 % | Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) | - NDA assigned a Target Action Date of February 25, 2026 -- Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or the... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 12,950 | -0,23 % | Astria Therapeutics, Inc. - 8-K, Current Report | ||
| MILESTONE PHARMACEUTICALS | 2,080 | +0,48 % | Milestone Pharmaceuticals Inc.: Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythmFDA approval in PSVT enables... ► Artikel lesen | |
| INHIBIKASE THERAPEUTICS | 1,990 | +20,61 % | Inhibikase: H.C. Wainwright startet Coverage mit "Buy" und 385 % Kurspotenzial | ||
| LB PHARMACEUTICALS | 21,530 | -2,14 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer | NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 1CM INC finden Sie auf Wallstreet Online.